Overall Fundamental outlook

*BAYERCROP makes the list of companies with the worst technicals at present.

Business Operations:

Sector: Basic Materials
Industry: Agricultural Inputs

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRise and other digital applications, such as drones for spray services, etc., as well as provides various technologies, such as remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics to monitor and manage crop growth, soil quality, weather patterns, and other factors. The company also exports its products. Bayer CropScience Limited was founded in 1863 and is based in Thane, India.

Revenue projections:

Revenue projections for BAYERCROP
Revenue projections for BAYERCROP

Bayer CropScience Limited's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.

Financial Ratios:

currentRatio 0.000000
forwardPE 28.558073
debtToEquity 3.687000
earningsGrowth 0.096000
revenueGrowth 0.174000
grossMargins 0.374600
operatingMargins 0.167760
trailingEps 131.870000
forwardEps 0.000000

With BAYERCROP's Forward PE in a favorable range, the stock appears reasonably priced compared to its earnings. This suggests that it's not overpriced and there is room for growth, providing an encouraging opportunity for investors seeking future value increases.

Price projections:

Price projections for BAYERCROP
Price projections for BAYERCROP

Price projections for BAYERCROP have been revised upward over time, signaling increasing optimism about the company's future. This steady increase reflects a positive outlook for BAYERCROP's growth and market performance.

Recommendation changes over time:

Recommendations trend for BAYERCROP
Recommendations trend for BAYERCROP


With analysts showing a buy bias for BAYERCROP, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning BAYERCROP as a safe and profitable place for investors to allocate their funds and seek growth.